CUTANEOUS MARKERS OF INSULIN RESISTANCE AND METABOLIC SYNDROME: DIAGNOSTIC VALUE AND IMPLICATIONS FOR EARLY INTERVENTION - A NARRATIVE REVIEW
DOI:
https://doi.org/10.31435/ijitss.4(52).2026.6873Keywords:
Acanthosis Nigricans, Insulin Resistance, Metabolic Syndrome, Obesity, Skin ManifestationsAbstract
Background: Insulin resistance and metabolic syndrome may remain clinically silent, while selected cutaneous findings are visible during routine examination. Their associations with metabolic abnormalities vary, and they are not diagnostic tests.
Objective: To summarize evidence linking selected skin findings with insulin resistance and metabolic syndrome and outline a cautious approach to metabolic assessment in dermatology and primary care.
Methods: A targeted narrative search of PubMed, Google Scholar and reference lists identified English-language guidelines, reviews, observational studies and relevant case series available through 31 October 2026. Search concepts covered insulin resistance, metabolic syndrome, acanthosis nigricans, acrochordons, xanthomas and related dermatoses. Evidence was synthesized qualitatively.
Results: Acanthosis nigricans has the clearest association with hyperinsulinemia and obesity-related metabolic risk, but diagnostic performance varies across populations and study designs. Multiple acrochordons are associated with dysglycemia and metabolic-syndrome components but are nonspecific. Eruptive xanthomas may signal severe hypertriglyceridemia. Hidradenitis suppurativa and psoriasis are associated with cardiometabolic comorbidity, while acne, hirsutism and female-pattern hair loss require consideration of hyperandrogenism and polycystic ovary syndrome. No single skin sign establishes or excludes insulin resistance or metabolic syndrome.
Conclusions: Selected skin findings can prompt risk assessment and guideline-based testing, particularly alongside central adiposity or other risk factors. They are clinical cues, not validated stand-alone tests. Prospective studies with standardized definitions are needed.
References
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., et al. (2009). Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation, 120(16), 1640–1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
Grundy, S. M., Cleeman, J. I., Daniels, S. R., et al. (2005). Diagnosis and management of the metabolic syndrome: An american heart association/national heart, lung, and blood institute scientific statement. Circulation, 112(17), 2735–2752. https://doi.org/10.1161/CIRCULATIONAHA.105.169404
Kassi, E., Pervanidou, P., Kaltsas, G., & Chrousos, G. (2011). Metabolic syndrome: Definitions and controversies. BMC Med, 9, 48. https://doi.org/10.1186/1741-7015-9-48
Grundy, S. M. (2016). Metabolic syndrome update. Trends Cardiovasc Med, 26(4), 364–373. https://doi.org/10.1016/j.tcm.2015.10.004
Higgins, S. P., Freemark, M., & Prose, N. S. (2008). Acanthosis nigricans: A practical approach to evaluation and management. Dermatol Online J, 14(9), 2. https://doi.org/10.5070/D37MF6G290
Napolitano, M., Megna, M., & Monfrecola, G. (2015). Insulin resistance and skin diseases. ScientificWorldJournal, 2015, 479354. https://doi.org/10.1155/2015/479354
Ponte, P., et al. (2017). Skin manifestations of insulin resistance: From a biochemical stance to a clinical diagnosis and management. Dermatol Ther (Heidelb), 7(1), 63–76. https://doi.org/10.1007/s13555-016-0160-3
Yosipovitch, G., DeVore, A., & Dawn, A. (2007). Obesity and the skin: Skin physiology and skin manifestations of obesity. J Am Acad Dermatol, 56(6), 901–916. https://doi.org/10.1016/j.jaad.2006.12.004
Shipman, A. R. & Millington, G. W. M. (2011). Obesity and the skin. Br J Dermatol, 165(4), 743–750. https://doi.org/10.1111/j.1365-2133.2011.10393.x
Muniyappa, R., Lee, S., Chen, H., & Quon, M. J. (2008). Current approaches for assessing insulin sensitivity and resistance in vivo: Advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab, 294(1), E15–E26. https://doi.org/10.1152/ajpendo.00645.2007
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004). Use and abuse of homa modeling. Diabetes Care, 27(6), 1487–1495. https://doi.org/10.2337/diacare.27.6.1487
Phiske, M. M. (2014). An approach to acanthosis nigricans. Indian Dermatol Online J, 5(3), 239–249. https://doi.org/10.4103/2229-5178.137765
Das, A., et al. (2022). Acanthosis nigricans: A review. J Clin Aesthet Dermatol, 15(11), 18–25. https://pubmed.ncbi.nlm.nih.gov/36698243/
Burke, J. P., Hale, D. E., Hazuda, H. P., & Stern, M. P. (1999). A quantitative scale of acanthosis nigricans. Diabetes Care, 22(10), 1655–1659. https://doi.org/10.2337/diacare.22.10.1655
Nguyen, T. T., Keil, M. F., Russell, D. L., et al. (2001). Relation of acanthosis nigricans to hyperinsulinemia and insulin sensitivity in overweight african american and white children. J Pediatr, 138(4), 474–480. https://doi.org/10.1067/mpd.2001.112617
Kong, A. S., Williams, R. L., Smith, M., et al. (2007). Acanthosis nigricans and diabetes risk factors: Prevalence in young persons seen in southwestern US primary care practices. Ann Fam Med, 5(3), 202–208. https://doi.org/10.1370/afm.678
Kluczynik, C. E. N., et al. (2012). Acanthosis nigricans and insulin resistance in overweight children and adolescents. An Bras Dermatol, 87(4), 531–537. https://doi.org/10.1590/S0365-05962012000400002
Ng, H. Y., et al. (2014). Acanthosis nigricans in obese chinese children. Pediatr Int, 56(3), E1–E5. https://pubmed.ncbi.nlm.nih.gov/24762331/
Das, A., et al. (2023). Association of acanthosis nigricans with metabolic syndrome: An analytic cross-sectional study. An Bras Dermatol, 98(4), 463–470. https://doi.org/10.1016/j.abd.2022.07.006
Gillespie, J., Roland-McGowan, J., Diehl, K., et al. (2026). Is acanthosis nigricans a marker for metabolic syndrome? A systematic review. Am J Clin Dermatol, 27(5), 945–957. https://doi.org/10.1007/s40257-026-01058-7
Sari, R., et al. (2010). The metabolic profile in patients with skin tags. Clin Exp Med, 10(3), 193–197. https://doi.org/10.1007/s10238-009-0086-5
Senel, E., Salmanoğlu, M., Solmazgül, E., & Berçik İnal, B. (2013). Acrochordons as a cutaneous sign of impaired carbohydrate metabolism, hyperlipidemia, liver enzyme abnormalities and hypertension: A case-control study. J Eur Acad Dermatol Venereol, 27(12), 2637–2643. https://doi.org/10.1111/j.1468-3083.2011.04396.x
Tamega, A. A., Aranha, A. M. P., Guiotoku, M. M., Miot, L. D. B., & Miot, H. A. (2010). Association between skin tags and insulin resistance. An Bras Dermatol, 85(1), 25–31. https://doi.org/10.1590/S0365-05962010000100003
Erdogan, B. S., et al. (2012). Association between acrochordons and the components of metabolic syndrome. J Dermatol, 39(2), 150–155. https://doi.org/10.1111/j.1346-8138.2011.01373.x
Kahana, M., Grossman, E., Feinstein, A., et al. (1987). Skin tags: A cutaneous marker for diabetes mellitus. Acta Derm Venereol, 67(2), 175–177. https://pubmed.ncbi.nlm.nih.gov/2437704/
Parker, F. (1985). Xanthomas and hyperlipidemias. J Am Acad Dermatol, 13(1), 1–30. https://doi.org/10.1016/S0190-9622(85)70134-6
Mija, L. A., Bergeron, C., Abi Chahine, C., et al. (2025). Clinical features and treatment outcomes of eruptive xanthomatosis: A systematic review. J Cutan Med Surg, 29(4), 399–400. https://doi.org/10.1177/12034754251316304
Lee, A., et al. (2016). Xanthelasma palpebrarum and cardiovascular risk factors: A systematic review and meta-analysis. J Am Acad Dermatol, 75(3), 593–600. https://pubmed.ncbi.nlm.nih.gov/27372515/
Garg, A., et al. (2018). Metabolic syndrome and cardiovascular disease among patients with hidradenitis suppurativa: A population-based study. J Am Acad Dermatol, 78(2), 291–297. https://doi.org/10.1016/j.jaad.2017.09.052
Sabat, R., et al. (2020). Hidradenitis suppurativa. Nat Rev Dis Primers, 6, 18. https://doi.org/10.1038/s41572-020-0149-1
Alikhan, A., et al. (2019). North american clinical management guidelines for hidradenitis suppurativa: Part i: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol, 81(1), 76–90. https://doi.org/10.1016/j.jaad.2019.02.067
Takeshita, J., Grewal, S., Langan, S. M., et al. (2017). Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol, 76(3), 377–390. https://doi.org/10.1016/j.jaad.2016.07.064
Armstrong, A. W., Harskamp, C. T., & Armstrong, E. J. (2012). The association between psoriasis and obesity: A systematic review and meta-analysis of observational studies. Nutr Diabetes, 2, e54. https://doi.org/10.1038/nutd.2012.26
Elmets, C. A., Leonardi, C. L., Davis, D. M. R., et al. (2019). Joint aad-npf guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol, 80(4), 1073–1113. https://doi.org/10.1016/j.jaad.2018.11.058
Teede, H. J., Tay, C. T., Laven, J. J. E., et al. (2023). Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril, 120(4), 767–793. https://doi.org/10.1016/j.fertnstert.2023.07.025
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., et al. (2013). Diagnosis and treatment of polycystic ovary syndrome: An endocrine society clinical practice guideline. J Clin Endocrinol Metab, 98(12), 4565–4592. https://doi.org/10.1210/jc.2013-2350
Carmina, E., Azziz, R., Bergfeld, W., et al. (2019). Female pattern hair loss and androgen excess: A report from the multidisciplinary androgen excess and PCOS committee. J Clin Endocrinol Metab, 104(7), 2875–2891. https://doi.org/10.1210/jc.2018-02548
American Diabetes Association Professional Practice Committee (2026). 2. Diagnosis and classification of diabetes: Standards of care in diabetes—2026. Diabetes Care, 49(Suppl 1). https://doi.org/10.2337/dc26-S002
US Preventive Services Task Force (2021). Screening for prediabetes and type 2 diabetes: US preventive services task force recommendation statement. JAMA, 326(8), 736–743. https://doi.org/10.1001/jama.2021.12531
International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: International Diabetes Federation; 2006. https://www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome.html
Sado, A., Tomaszewska, M., Wójcik, S., & Rulkiewicz, A. (2026). Skin as a metabolic organ: Dermatologic markers of morbid obesity and their role in risk stratification and treatment monitoring. Diagnostics, 16(9), 1314. https://doi.org/10.3390/diagnostics16091314
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Olena Abramchuk, Vladyslav Tetarchuk, Vlada Tetarchuk, Anastasiia Tanko, Andrei Trutsko, Artem Shchebetun, Daria Shchebetun

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

